Aegis, Fordham assist in raising funds for general corporate purposes
By Devika Patel
Knoxville, Tenn., July 18 - Ampio Pharmaceuticals, Inc. said it settled a $17.84 million public offering of stock. The deal priced for $15 million with a $2.25 million greenshoe on July 12.
The company sold 5,488,960 common shares at $3.25 per share. The price per share reflects a 24.1% discount to the company's $4.28 closing share price on July 11.
Aegis Capital Corp. and Fordham Financial Management, Inc. were the bookrunners.
Proceeds will be added to the company's general funds and used for general corporate purposes.
Ampio is a Greenwood Village, Colo.-based development-stage pharmaceutical company.
| Issuer: | Ampio Pharmaceuticals, Inc.
|
| Issue: | Common stock
|
| Amount: | $17,839,120 (including $2,250,008 greenshoe)
|
| Shares: | 5,488,960
|
| Price: | $3.25
|
| Warrants: | No
|
| Bookrunners: | Aegis Capital Corp. and Fordham Financial Management, Inc.
|
| Pricing date: | July 12
|
| Settlement date: | July 18
|
| Stock symbol: | Nasdaq: AMPE
|
| Stock price: | $3.66 at close July 12
|
| Market capitalization: | $94.11 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
